Pharmaceutical Executive Digest Europe - April 1, 2009 - (Page 9) Outlook Still picky While publicly-held CROs represent the highest profile targets, we are aware of several well-known privately held CMOs whose owners have put them on the block and which are attracting considerable interest from investors. Private investors aren’t the only buyers either: publicly-held CROs such as PPD (NC, USA), which recently acquired the Eastern Europe CRO AbCRO (Bulgaria), are also taking the opportunity to make deals that help flesh out their capabilities. The lesson is that despite the doom and gloom in the financial media, there are still good businesses to invest in and institutions with money to invest in them. The smart money seems to be saying that pharmaceutical services will be a great business well into the future. Jim Miller is the founder and president of PharmSource and a regular contributor to Pharmaceutical Technology, Pharmaceutical Technology Europe and BioPharm magazines. The lesson is that, despite the doom and gloom in the financial media, there are still good businesses to invest in and institutions with money to invest in them. This doesn’t mean that investors aren’t being picky, however. Investors are focusing on CROs with strong market positions and viable business models, mindful that the services industry will experience a shake out in coming months. We know of several high-profile companies that have been unsuccessful at finding private investors in the last year. The best things in life are for sharing Forward your copy of Pharm Exec Europe to a friend Don’t forget to forward your weekly issue of the Pharm Exec Europe digest to a friend or colleague or you can subscribe by clicking here 1 NEWS 2 11 FROM THE EDITOR / NEWS CALENDAR 3 MERCK SERONO 7 PHARMA’S GREAT HOPE 10 NEWS 12 LAST WORDS 13 ON THE MOVE http://www.pharmexeceurope.com/europharmexec/newsletter/subscribeNewsletter.jsp http://www.pharmsource.com http://www.pharmtech.com http://www.ptemag.com http://biopharminternational.findpharma.com/
For optimal viewing of this digital publication, please enable JavaScript and then refresh the page. If you would like to try to load the digital publication without using Flash Player detection, please click here.